Covered recipient · General Payments record
SHANLEY BANAAG
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2022–2024
$3,418.76
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,557.63 | 57 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PharmaEssentia USA Corporation | $151.47 | 5 |
| SOBI, INC | $136.35 | 4 |
| Genentech USA, Inc. | $124.90 | 2 |
| Regeneron Healthcare Solutions, Inc. | $121.53 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.93 | 4 |
| Alexion Pharmaceuticals, Inc. | $97.38 | 3 |
| AVEO Pharmaceuticals, Inc. | $96.46 | 4 |
| Acerta Pharma LLC | $84.37 | 4 |
| EISAI INC. | $57.80 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $56.93 | 2 |
| Stemline Therapeutics Inc. | $55.00 | 2 |
| Deciphera Pharmaceuticals Inc. | $53.27 | 2 |
| Merck Sharp & Dohme Corporation | $47.13 | 2 |
| Incyte Corporation | $44.58 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.33 | 2 |
| Daiichi Sankyo Inc. | $41.55 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $34.52 | 1 |
| Geron Corporation | $26.50 | 1 |
| Janssen Biotech, Inc. | $24.80 | 1 |
| Pharmacosmos Therapeutics Inc. | $24.30 | 1 |
| Genmab U.S., Inc. | $23.62 | 1 |
| ARRAY BIOPHARMA INC | $21.87 | 1 |
| ABBVIE INC. | $21.18 | 1 |
| Tempus AI, Inc | $19.69 | 1 |
| Emmaus Medical, Inc. | $18.08 | 1 |
| Astellas Pharma US Inc | $15.64 | 1 |
| CSL Behring | $14.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.